MedTrace Logo

rTMS to Enhance Cognitive Performance and Promote Resilience

NCT04123496 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-10-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the most effective dose of brief, non-invasive brain stimulation (repetitive transcranial magnetic stimulation, rTMS) for improving cognitive functions such as attention and memory as well as to improve the ability to recover from stressful situations (stress resilience).

Conditions

  • Cognition
  • Stress Reaction

Interventions

DEVICE

rTMS

Device: Repetitive Transcranial Magnetic Stimulation (rTMS) MagVenture MagPro TMS System would be utilized to deliver 3-minute sessions of intermittent theta burst to left dorsolateral prefrontal cortex.

Sponsors & Collaborators

  • National Aeronautics and Space Administration (NASA)

    collaborator FED

  • The Translational Research Institute for Space Health (TRISH)

    collaborator UNKNOWN

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Donna Roberts, MD · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2021-09-27
Completion
2021-10-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04123496 on ClinicalTrials.gov